Abstract

DNA interstrand crosslinks (ICLs) are covalently bound DNA lesions, which are commonly induced by chemotherapeutic drugs, such as cisplatin and mitomycin C or endogenous byproducts of metabolic processes. This type of DNA lesion can block ongoing RNA transcription and DNA replication and thus cause genome instability and cancer. Several cellular defense mechanism, such as the Fanconi anemia pathway have developed to ensure accurate repair and DNA replication when ICLs are present. Various structure-specific nucleases and translesion synthesis (TLS) polymerases have come into focus in relation to ICL bypass. Current models propose that a structure-specific nuclease incision is needed to unhook the ICL from the replication fork, followed by the activity of a low-fidelity TLS polymerase enabling replication through the unhooked ICL adduct. This review focuses on how, in parallel with the Fanconi anemia pathway, PCNA interactions and ICL-induced PCNA ubiquitylation regulate the recruitment, substrate specificity, activity, and coordinated action of certain nucleases and TLS polymerases in the execution of stalled replication fork rescue via ICL bypass.

Highlights

  • Our genome is constantly exposed to different exogenous and endogenous DNA damaging factors

  • We point out the similarities between the Fanconi Anemia (FA) and Rad6Rad18 pathways in dealing with the interstrand crosslinks (ICLs) at the stalled replication fork (Figure 1) and summarize our current knowledge on ICLunhooking nucleases and ICL bypass polymerases (Figure 2), and reach the following conclusions

  • Several proteins implicated in ICL repair can interact with Ub-ID2 as well as Ub-proliferating cell nuclear antigen (PCNA), such as the FAN1 nuclease, which exhibits Pol iota exhibit conserved PCNAinteracting (PIP) and ubiquitin−binding zinc finger (UBZ) domains for timely binding to the stalled fork (Buzon et al, 2018)

Read more

Summary

Frontiers in Cell and Developmental Biology

DNA interstrand crosslinks (ICLs) are covalently bound DNA lesions, which are commonly induced by chemotherapeutic drugs, such as cisplatin and mitomycin C or endogenous byproducts of metabolic processes. This type of DNA lesion can block ongoing RNA transcription and DNA replication and cause genome instability and cancer. Several cellular defense mechanism, such as the Fanconi anemia pathway have developed to ensure accurate repair and DNA replication when ICLs are present. This review focuses on how, in parallel with the Fanconi anemia pathway, PCNA interactions and ICL-induced PCNA ubiquitylation regulate the recruitment, substrate specificity, activity, and coordinated action of certain nucleases and TLS polymerases in the execution of stalled replication fork rescue via ICL bypass

INTRODUCTION
SENSORS AND TRANSDUCERS OF ICL REPAIR PATHWAYS
TLS POLYMERASES PROCESS SUBSTRATES UNHOOKED BY NUCLEASES
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call